Key mechanisms governing resolution of lung inflammation

Seminars in Immunopathology

Volumn 38, Issue 4, 2016, Pages 425-448

  Robb, C T ^a   Regan, K H ^a   Dorward, D A ^a   Rossi, A G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Efferocytosis; Eosinophils; ETosis; Lung diseases; Lung inflammation; Macrophages; Neutrophils; Pro resolution mediators

Indexed keywords

CD59 ANTIGEN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FATTY ACID; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; LIPOXIN; LIPOXYGENASE; MARESIN 1; RESOLVIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ASTHMA; BASOPHIL; CELL ADHESION; CELL INTERACTION; CYTOKINE RELEASE; DENDRITIC CELL; EFFEROCYTOSIS; EOSINOPHIL; FATTY ACID SYNTHESIS; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL DEATH; CYTOLOGY; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; LIPID METABOLISM; LUNG DISEASES; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHAGOCYTE; RESPIRATORY MUCOSA;

ANIMALS; APOPTOSIS; CELL DEATH; CYTOKINES; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; LIPID METABOLISM; LUNG DISEASES; PHAGOCYTES; PHAGOCYTOSIS; RESPIRATORY MUCOSA;

EID: 84964440104     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-016-0560-6     Document Type: Review

References (251)

1. Leitch AE, Duffin R, Haslett C, Rossi AG (2008) Relevance of granulocyte apoptosis to resolution of inflammation at the respiratory mucosa. Mucosal Immunol 1:350–363. doi:10.1038/mi.2008.31
2. Nathan C (2002) Points of control in inflammation. Nature 420:846–852. doi:10.1038/nature01320
3. Nathan C, Ding A (2010) Nonresolving inflammation. Cell 140:871–882. doi:10.1016/j.cell.2010.02.029
4. Serhan CN, Brain SD, Buckley CD et al (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:325–332. doi:10.1096/fj.06-7227rev
5. Levy BD, Clish CB, Schmidt B et al (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612–619. doi:10.1038/89759
6. Bannenberg GL, Chiang N, Ariel A et al (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 174:4345–4355
7. Serhan CN, Chiang N (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153:S200–S215. doi:10.1038/sj.bjp.0707489
8. Buckley CD, Gilroy DW, Serhan CN (2014) Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 40:315–327. doi:10.1016/j.immuni.2014.02.009
9. Michlewska S, McColl A, Rossi AG et al (2007) Clearance of dying cells and autoimmunity. Autoimmunity 40:267–273. doi:10.1080/08916930701357208
10. Poon IKH, Lucas CD, Rossi AG, Ravichandran KS (2014) Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 14:166–180. doi:10.1038/nri3607
11. Motwani MP, Gilroy DW (2015) Macrophage development and polarization in chronic inflammation. Semin Immunol 27:257–266. doi:10.1016/j.smim.2015.07.002
12. Persson C, Uller L (2010) Transepithelial exit of leucocytes: inflicting, reflecting or resolving airway inflammation? Thorax 65:1111–1115. doi:10.1136/thx.2009.133363
13. Gilroy DW, Lawrence T, Perretti M, Rossi AG (2004) Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3:401–416. doi:10.1038/nrd1383
14. Duffin R, Leitch AE, Fox S et al (2010) Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol Rev 236:28–40. doi:10.1111/j.1600-065X.2010.00922.x
15. Alessandri AL, Sousa LP, Lucas CD et al (2013) Resolution of inflammation: mechanisms and opportunity for drug development. Pharmacol Ther 139:189–212. doi:10.1016/j.pharmthera.2013.04.006
16. Perretti M, Leroy X, Bland EJ, Montero-Melendez T (2015) Resolution pharmacology: opportunities for therapeutic innovation in inflammation. Trends Pharmacol Sci 36:737–755. doi:10.1016/j.tips.2015.07.007
17. Sonnenberg GF, Artis D (2015) Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 21:698–708. doi:10.1038/nm.3892
18. Gilroy D, De Maeyer R (2015) New insights into the resolution of inflammation. Semin Immunol 27:161–168. doi:10.1016/j.smim.2015.05.003
19. Tak T, Tesselaar K, Pillay J et al (2013) What’s your age again? Determination of human neutrophil half-lives revisited. J Leukoc Biol 94:595–601. doi:10.1189/jlb.1112571
20. Borregaard N, Cowland JB (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503–3521
21. Serhan CN (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25:101–137. doi:10.1146/annurev.immunol.25.022106.141647
22. Jones HR, Robb CT, Perretti M, Rossi AG (2016) The role of neutrophils in inflammation resolution. Semin Immunol. doi:10.1016/j.smim.2016.03.007
23. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–57
24. Fridlender ZG, Albelda SM (2012) Tumor-associated neutrophils: friend or foe? Carcinogenesis 33:949–955. doi:10.1093/carcin/bgs123
25. Kobayashi Y (2015) Neutrophil biology: an update. EXCLI J 14:220–227. doi: 10.17179/excli2015-102
26. Buckley CD, Ross EA, McGettrick HM et al (2006) Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J Leukoc Biol 79:303–311. doi:10.1189/jlb.0905496
27. Lucas CD, Hoodless LJ, Rossi AG (2014) Swimming against the tide: drugs drive neutrophil reverse migration. Sci Transl Med 6:225fs9. doi:10.1126/scitranslmed.3008666
28. Robertson AL, Holmes GR, Bojarczuk AN et al (2014) A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism. Sci Transl Med 6:225ra29. doi:10.1126/scitranslmed.3007672
29. Tauzin S, Starnes TW, Becker FB et al (2014) Redox and Src family kinase signaling control leukocyte wound attraction and neutrophil reverse migration. J Cell Biol 207:589–598. doi:10.1083/jcb.201408090
30. Colom B, Bodkin JV, Beyrau M et al (2015) Leukotriene B4-neutrophil elastase axis drives neutrophil reverse transendothelial cell migration in vivo. Immunity 42:1075–1086. doi:10.1016/j.immuni.2015.05.010
31. Ellett F, Elks PM, Robertson AL, et al. (2015) Defining the phenotype of neutrophils following reverse migration in zebrafish. J Leukoc Biol jlb.3MA0315–105R. doi: 10.1189/jlb.3MA0315-105R
32. Powell DR, Huttenlocher A (2016) Neutrophils in the tumor microenvironment. Trends Immunol 37:41–52. doi:10.1016/j.it.2015.11.008
33. Yousefi S, Gold JA, Andina N et al (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 14:949–53. doi:10.1038/nm.1855
34. Ueki S, Melo RCN, Ghiran I et al (2013) Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood 121:2074–2083. doi:10.1182/blood-2012-05-432088
35. Stern M, Meagher L, Savill J, Haslett C (1992) Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 148:3543–9
36. Henderson WR, Jörg A, Klebanoff SJ (1982) Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4. J Immunol 128:2609–2613
37. Henderson WR, Jong EC, Klebanoff SJ (1980) Binding of eosinophil peroxidase to mast cell granules with retention of peroxidatic activity. J Immunol 124:1383–1388
38. Rosenberg HF, Domachowske JB (2001) Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70:691–698
39. Drake MG, Bivins-Smith ER, Proskocil BJ et al (2016) Human and mouse eosinophils have antiviral activity against parainfluenza virus. Am J Respir Cell Mol Biol. doi:10.1165/rcmb.2015-0405OC
40. Felton JM, Lucas CD, Rossi AG, Dransfield I (2014) Eosinophils in the lung—modulating apoptosis and efferocytosis in airway inflammation. Front Immunol. doi:10.3389/fimmu.2014.00302
41. Falcone FH, Haas H, Gibbs BF (2000) The human basophil: a new appreciation of its role in immune responses. Blood 96:4028–4038
42. Gordon S, Plüddemann A, Martinez Estrada F (2014) Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol Rev 262:36–55. doi:10.1111/imr.12223
43. Hussell T, Bell TJ (2014) Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol 14:81–93. doi:10.1038/nri3600
44. Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6:13. doi:10.12703/P6-13
45. Murray PJ, Allen JE, Biswas SK et al (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:14–20. doi:10.1016/j.immuni.2014.06.008
46. Savill J (1997) Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 53:491–508
47. Kaur M, Bell T, Salek-Ardakani S, Hussell T (2015) Macrophage adaptation in airway inflammatory resolution. Eur Respir Rev 24:510–515. doi:10.1183/16000617.0030-2015
48. Kawkitinarong K, Linz-McGillem L, Birukov KG, Garcia JGN (2004) Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am J Respir Cell Mol Biol 31:517–527. doi:10.1165/rcmb.2003-0432OC
49. Crosby LM, Waters CM (2010) Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 298:L715–L731. doi:10.1152/ajplung.00361.2009
50. Borish L, Joseph BZ (1992) Inflammation and the allergic response. Med Clin N Am 76:765–787
51. Amin K (2012) The role of mast cells in allergic inflammation. Respir Med 106:9–14. doi:10.1016/j.rmed.2011.09.007
52. Culley FJ (2009) Natural killer cells in infection and inflammation of the lung. Immunology 128:151–163. doi:10.1111/j.1365-2567.2009.03167.x
53. Condon TV, Sawyer RT, Fenton MJ, Riches DWH (2011) Lung dendritic cells at the innate-adaptive immune interface. J Leukoc Biol 90:883–895. doi:10.1189/jlb.0311134
54. Fox S, Leitch AE, Duffin R et al (2010) Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J Innate Immun 2:216–227. doi:10.1159/000284367
55. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312–1316
56. Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383–424. doi:10.1146/annurev.biochem.68.1.383
57. Maianski NA, Roos D, Kuijpers TW (2003) Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils. Blood 101:1987–1995. doi:10.1182/blood-2002-02-0522
58. Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491–501
59. Schug ZT, Gonzalvez F, Houtkooper RH et al (2011) BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane. Cell Death Differ 18:538–548. doi:10.1038/cdd.2010.135
60. Arandjelovic S, Ravichandran KS (2015) Phagocytosis of apoptotic cells in homeostasis. Nat Immunol 16:907–917. doi:10.1038/ni.3253
61. Truman LA, Ford CA, Pasikowska M et al (2008) CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 112:5026–5036. doi:10.1182/blood-2008-06-162404
62. Lauber K, Bohn E, Kröber SM et al (2003) Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717–730
63. Gude DR, Alvarez SE, Paugh SW et al (2008) Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-get-me” signal. FASEB J 22:2629–2638. doi:10.1096/fj.08-107169
64. Elliott MR, Chekeni FB, Trampont PC et al (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282–286. doi:10.1038/nature08296
65. Gardai SJ, Bratton DL, Ogden CA, Henson PM (2006) Recognition ligands on apoptotic cells: a perspective. J Leukoc Biol 79:896–903. doi:10.1189/jlb.1005550
66. Fadok VA, Voelker DR, Campbell PA et al (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207–2216
67. Fadok VA, Bratton DL, Rose DM et al (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405:85–90. doi:10.1038/35011084
68. Hochreiter-Hufford A, Ravichandran KS (2013) Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspe ct Biol 5:a008748. doi:10.1101/cshperspect.a008748
69. Serhan CN, Chiang N, Dalli J, Levy BD (2014) Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol a016311. doi: 10.1101/cshperspect.a016311
70. Cavassani KA, Ishii M, Wen H et al (2008) TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 205:2609–2621. doi:10.1084/jem.20081370
71. Zitvogel L, Kepp O, Kroemer G (2010) Decoding cell death signals in inflammation and immunity. Cell 140:798–804. doi:10.1016/j.cell.2010.02.015
72. Kono H, Rock KL (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8:279–289. doi:10.1038/nri2215
73. Brinkmann V, Reichard U, Goosmann C et al (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–5
74. Yousefi S, Mihalache C, Kozlowski E et al (2009) Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ 16:1438–44. doi:10.1038/cdd.2009.96
75. Pilsczek FH, Salina D, Poon KKH et al (2010) A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol 185:7413–7425. doi:10.4049/jimmunol.1000675
76. Fuchs TA, Abed U, Goosmann C et al (2007) Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176:231–41
77. Urban CF, Ermert D, Schmid M et al (2009) Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 5:e1000639. doi:10.1371/journal.ppat.1000639
78. Neeli I, Radic M (2012) Knotting the NETs: analyzing histone modifications in neutrophil extracellular traps. Arthritis Res Ther 14:115. doi:10.1186/ar3773
79. Neeli I, Dwivedi N, Khan S, Radic M (2009) Regulation of extracellular chromatin release from neutrophils. J Innate Immun 1:194–201. doi:10.1159/000206974
80. Gray RD, Lucas CD, Mackellar A et al (2013) Activation of conventional protein kinase C (PKC) is critical in the generation of human neutrophil extracellular traps. J Inflamm (Lond) 10:12. doi:10.1186/1476-9255-10-12
81. Saitoh T, Komano J, Saitoh Y et al (2012) Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe 12:109–116. doi:10.1016/j.chom.2012.05.015
82. Urban CF, Reichard U, Brinkmann V, Zychlinsky A (2006) Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol 8:668–76
83. Abi Abdallah DS, Lin C, Ball CJ et al (2012) Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps. Infect Immun 80:768–777. doi:10.1128/IAI.05730-11
84. Wartha F, Beiter K, Albiger B et al (2007) Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol 9:1162–1171. doi:10.1111/j.1462-5822.2006.00857.x
85. Buchanan JT, Simpson AJ, Aziz RK et al (2006) DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol 16:396–400. doi:10.1016/j.cub.2005.12.039
86. Steinberg BE, Grinstein S (2007) Unconventional roles of the NADPH oxidase: signaling, ion homeostasis, and cell death. Sci STKE 2007:pe11. doi:10.1126/stke.3792007pe11
87. Wartha F, Henriques-Normark B (2008) ETosis: a novel cell death pathway. Sci Signal 1:pe25. doi:10.1126/stke.121pe25
88. Robb CT, Dyrynda EA, Gray RD et al (2014) Invertebrate extracellular phagocyte traps show that chromatin is an ancient defence weapon. Nat Commun 5:4627. doi:10.1038/ncomms5627
89. Kasama T, Miwa Y, Isozaki T et al (2005) Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy 4:273–279
90. Zawrotniak M, Rapala-Kozik M (2013) Neutrophil extracellular traps (NETs)—formation and implications. Acta Biochim Pol 60:277–284
91. Bosmann M, Grailer JJ, Ruemmler R et al (2013) Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J 27:5010–5021. doi:10.1096/fj.13-236380
92. Caudrillier A, Kessenbrock K, Gilliss BM et al (2012) Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 122:2661–2671. doi:10.1172/JCI61303
93. Narasaraju T, Yang E, Samy RP et al (2011) Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 179:199–210. doi:10.1016/j.ajpath.2011.03.013
94. Manzenreiter R, Kienberger F, Marcos V et al (2012) Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. J Cyst Fibros 11:84–92. doi:10.1016/j.jcf.2011.09.008
95. Dwyer M, Shan Q, Ortona SD et al (2014) Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor. J Innate Immun 6:765–779. doi:10.1159/000363242
96. Fuxman Bass JI, Russo DM, Gabelloni ML et al (2010) Extracellular DNA: a major proinflammatory component of Pseudomonas aeruginosa biofilms. J Immunol 184:6386–6395. doi:10.4049/jimmunol.0901640
97. Young RL, Malcolm KC, Kret JE et al (2011) Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS One 6:e23637. doi:10.1371/journal.pone.0023637
98. Dworski R, Simon H-U, Hoskins A, Yousefi S (2011) Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol 127:1260–1266. doi:10.1016/j.jaci.2010.12.1103
99. Grabcanovic-Musija F, Obermayer A, Stoiber W et al (2015) Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation. Respir Res. doi:10.1186/s12931-015-0221-7
100. Pedersen F, Marwitz S, Holz O et al (2015) Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients. Respir Med 109:1360–1362. doi:10.1016/j.rmed.2015.08.008
101. Ramos-Kichik V, Mondragón-Flores R, Mondragón-Castelán M et al (2009) Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis (Edinb) 89:29–37. doi:10.1016/j.tube.2008.09.009
102. Cheng OZ, Palaniyar N (2013) NET balancing: a problem in inflammatory lung diseases. Front Immunol. doi:10.3389/fimmu.2013.00001
103. Röhm M, Grimm MJ, Auria ACD et al (2014) NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. Infect Immun 82:1766–1777. doi:10.1128/IAI.00096-14
104. Coxon A, Rieu P, Barkalow FJ et al (1996) A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 5:653–666
105. Romani L, Fallarino F, De Luca A et al (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451:211–215. doi:10.1038/nature06471
106. Ryter SW, Choi AMK (2015) Autophagy in lung disease pathogenesis and therapeutics. Redox Biol 4:215–225. doi:10.1016/j.redox.2014.12.010
107. Ponpuak M, Davis AS, Roberts EA et al (2010) Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 32:329–341. doi:10.1016/j.immuni.2010.02.009
108. Zhang R, Chi X, Wang S et al (2014) The regulation of autophagy by influenza A virus, the regulation of autophagy by influenza A virus. BioMed Res Int 2014:498083. doi:10.1155/2014/498083
109. Lam HC, Cloonan SM, Bhashyam AR et al (2013) Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction. J Clin Invest 123:5212–5230. doi:10.1172/JCI69636
110. Qing DY, Conegliano D, Shashaty MGS et al (2014) Red blood cells induce necroptosis of lung endothelial cells and increase susceptibility to lung inflammation. Am J Respir Crit Care Med 190:1243–1254. doi:10.1164/rccm.201406-1095OC
111. Kitur K, Parker D, Nieto P et al (2015) Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog 11:e1004820. doi:10.1371/journal.ppat.1004820
112. Pouwels SD, Zijlstra GJ, van der Toorn M, et al. (2015) Cigarette smoke-induced necroptosis and DAMP release trigger neutrophilic airway inflammation in mice. Am J Physiol Lung Cell Mol Physiol ajplung.00174.2015. doi: 10.1152/ajplung.00174.2015
113. Parnaik R, Raff MC, Scholes J (2000) Differences between the clearance of apoptotic cells by professional and non-professional phagocytes. Curr Biol 10:857–860
114. Wood W, Turmaine M, Weber R et al (2000) Mesenchymal cells engulf and clear apoptotic footplate cells in macrophageless PU.1 null mouse embryos. Development 127:5245–5252
115. Blume KE, Soeroes S, Keppeler H et al (2012) Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic “find-me” signal. J Immunol 188:135–145. doi:10.4049/jimmunol.1004073
116. Arur S, Uche UE, Rezaul K et al (2003) Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 4:587–598
117. Bournazou I, Pound JD, Duffin R et al (2009) Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest 119:20–32. doi:10.1172/JCI36226
118. Bournazou I, Mackenzie KJ, Duffin R et al (2010) Inhibition of eosinophil migration by lactoferrin. Immunol Cell Biol 88:220–223. doi:10.1038/icb.2009.86
119. Park D, Tosello-Trampont A-C, Elliott MR et al (2007) BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450:430–434. doi:10.1038/nature06329
120. Park S-Y, Jung M-Y, Kim H-J et al (2008) Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ 15:192–201. doi:10.1038/sj.cdd.4402242
121. Kobayashi N, Karisola P, Peña-Cruz V et al (2007) TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27:927–940. doi:10.1016/j.immuni.2007.11.011
122. Nakayama M, Akiba H, Takeda K et al (2009) Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113:3821–3830. doi:10.1182/blood-2008-10-185884
123. Lee S-J, So I-S, Park S-Y, Kim I-S (2008) Thymosin beta4 is involved in stabilin-2-mediated apoptotic cell engulfment. FEBS Lett 582:2161–2166. doi:10.1016/j.febslet.2008.03.058
124. Park S-Y, Kang K-B, Thapa N et al (2008) Requirement of adaptor protein GULP during stabilin-2-mediated cell corpse engulfment. J Biol Chem 283:10593–10600. doi:10.1074/jbc.M709105200
125. Toda S, Hanayama R, Nagata S (2012) Two-step engulfment of apoptotic cells. Mol Cell Biol 32:118–125. doi:10.1128/MCB.05993-11
126. Hanayama R, Tanaka M, Miwa K et al (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature 417:182–187. doi:10.1038/417182a
127. Anderson HA, Maylock CA, Williams JA et al (2003) Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 4:87–91. doi:10.1038/ni871
128. Ishimoto Y, Ohashi K, Mizuno K, Nakano T (2000) Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem 127:411–417
129. Gardai SJ, McPhillips KA, Frasch SC et al (2005) Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123:321–334. doi:10.1016/j.cell.2005.08.032
130. Obeid M, Tesniere A, Ghiringhelli F et al (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54–61. doi:10.1038/nm1523
131. Liu Y, Cousin JM, Hughes J et al (1999) Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol 162:3639–3646
132. Giles KM, Ross K, Rossi AG et al (2001) Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J Immunol 167:976–986
133. McColl A, Bournazos S, Franz S et al (2009) Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol 183:2167–2175. doi:10.4049/jimmunol.0803503
134. Scott RS, McMahon EJ, Pop SM et al (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411:207–211. doi:10.1038/35075603
135. Choi J-Y, Park H-J, Lee Y-J et al (2013) Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation. J Pharmacol Exp Ther 344:447–458. doi:10.1124/jpet.112.199778
136. Thorp E, Vaisar T, Subramanian M et al (2011) Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem 286:33335–33344. doi:10.1074/jbc.M111.263020
137. Lee Y-J, Lee S-H, Youn Y-S et al (2012) Preventing cleavage of Mer promotes efferocytosis and suppresses acute lung injury in bleomycin treated mice. Toxicol Appl Pharmacol 263:61–72. doi:10.1016/j.taap.2012.05.024
138. Marwick JA, Dorward DA, Lucas CD et al (2013) Oxygen levels determine the ability of glucocorticoids to influence neutrophil survival in inflammatory environments. J Leukoc Biol 94:1285–1292. doi:10.1189/jlb.0912462
139. Perretti M, Acquisto FD (2009) Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9:62–70. doi:10.1038/nri2470
140. Perretti M, Chiang N, La M et al (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8:1296–1302. doi:10.1038/nm786
141. Perretti M, Christian H, Wheller SK et al (2000) Annexin I is stored within gelatinase granules of human neutrophil and mobilized on the cell surface upon adhesion but not phagocytosis. Cell Biol Int 24:163–174. doi:10.1006/cbir.1999.0468
142. Maderna P, Yona S, Perretti M, Godson C (2005) Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac2–26. J Immunol 174:3727–3733. doi:10.4049/jimmunol.174.6.3727
143. Scannell M, Flanagan MB, deStefani A et al (2007) Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 178:4595–4605
144. Goulding NJ, Godolphin JL, Sharland PR et al (1990) Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 335:1416–1418
145. Mulla A, LeRoux C, Solito E, Buckingham JC (2005) Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. J Clin Endocrinol Metab 90:557–562. doi:10.1210/jc.2004-1230
146. Vago JP, Nogueira CRC, Tavares LP et al (2012) Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol 92:249–258. doi:10.1189/jlb.0112008
147. Morimoto K, Janssen WJ, Fessler MB et al (2006) Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 176:7657–7665
148. Yun JH, Henson PM, Tuder RM (2008) Phagocytic clearance of apoptotic cells: role in lung disease. Expert Rev Respir Med 2:753–765. doi:10.1586/17476348.2.6.753
149. Grabiec AM, Hussell T (2016) The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation. Semin Immunopathol. doi:10.1007/s00281-016-0555-3
150. Dockrell DH, Marriott HM, Prince LR et al (2003) Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J Immunol 171:5380–5388
151. Aberdein JD, Cole J, Bewley MA et al (2013) Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing. Clin Exp Immunol 174:193–202. doi:10.1111/cei.12170
152. Curtis JL, Todt JC, Hu B et al (2009) Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake. Front Biosci (Landmark Ed) 14:2631–2646
153. Janssen WJ, McPhillips KA, Dickinson MG et al (2008) Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am J Respir Crit Care Med 178:158–167. doi:10.1164/rccm.200711-1661OC
154. McCubbrey AL, Curtis JL (2013) Efferocytosis and lung disease. Chest 143:1750–1757. doi:10.1378/chest.12-2413
155. Xiong Z, Leme AS, Ray P et al (2011) CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-α and IL-6 and promote cigarette smoke-induced emphysema. J Immunol 186:3206–3214. doi:10.4049/jimmunol.1003221
156. Desch AN, Randolph GJ, Murphy K et al (2011) CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J Exp Med 208:1789–1797. doi:10.1084/jem.20110538
157. Walsh GM, Sexton DW, Blaylock MG, Convery CM (1999) Resting and cytokine-stimulated human small airway epithelial cells recognize and engulf apoptotic eosinophils. Blood 94:2827–2835
158. Sexton DW, Blaylock MG, Walsh GM (2001) Human alveolar epithelial cells engulf apoptotic eosinophils by means of integrin- and phosphatidylserine receptor-dependent mechanisms: a process upregulated by dexamethasone. J Allergy Clin Immunol 108:962–969. doi:10.1067/mai.2001.119414
159. Juncadella IJ, Kadl A, Sharma AK et al (2013) Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature 493:547–551. doi:10.1038/nature11714
160. Samuelsson B, Dahlén SE, Lindgren JA et al (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171–1176
161. Levy BD, Serhan CN (2014) Resolution of acute inflammation in the lung. Annu Rev Physiol 76:467–492. doi:10.1146/annurev-physiol-021113-170408
162. Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349–361. doi:10.1038/nri2294
163. Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:92–101. doi:10.1038/nature13479
164. Gilroy DW, Colville-Nash PR, Willis D et al (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5:698–701. doi:10.1038/9550
165. Fukunaga K, Kohli P, Bonnans C et al (2005) Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 174:5033–5039
166. Schwab JM, Chiang N, Arita M, Serhan CN (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447:869–874. doi:10.1038/nature05877
167. Ye RD, Boulay F, Wang JM et al (2009) International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61:119–161. doi:10.1124/pr.109.001578
168. Serhan CN, Hamberg M, Samuelsson B (1984) Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A 81:5335–5339
169. Serhan CN, Sheppard KA (1990) Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J Clin Invest 85:772–780. doi:10.1172/JCI114503
170. Levy BD, Romano M, Chapman HA et al (1993) Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest 92:1572–1579. doi:10.1172/JCI116738
171. Chiang N, Serhan CN, Dahlén S-E et al (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 58:463–487. doi:10.1124/pr.58.3.4
172. Krishnamoorthy S, Recchiuti A, Chiang N et al (2012) Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 180:2018–2027. doi:10.1016/j.ajpath.2012.01.028
173. Krishnamoorthy S, Recchiuti A, Chiang N et al (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 107:1660–1665. doi:10.1073/pnas.0907342107
174. Norling LV, Dalli J, Flower RJ et al (2012) Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol 32:1970–1978. doi:10.1161/ATVBAHA.112.249508
175. Arita M, Ohira T, Sun Y-P et al (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 178:3912–3917
176. Serhan CN, Gotlinger K, Hong S et al (2006) Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 176:1848–1859
177. Marcheselli VL, Hong S, Lukiw WJ et al (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278:43807–43817. doi:10.1074/jbc.M305841200
178. Serhan CN, Yang R, Martinod K et al (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 206:15–23. doi:10.1084/jem.20081880
179. Dalli J, Zhu M, Vlasenko NA et al (2013) The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB J 27:2573–2583. doi:10.1096/fj.13-227728
180. Serhan CN, Dalli J, Karamnov S et al (2012) Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J 26:1755–1765. doi:10.1096/fj.11-201442
181. Levy BD, Bonnans C, Silverman ES et al (2005) Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 172:824–830. doi:10.1164/rccm.200410-1413OC
182. Karp CL, Flick LM, Park KW et al (2004) Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol 5:388–392. doi:10.1038/ni1056
183. Sanak M, Levy BD, Clish CB et al (2000) Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 16:44–49
184. Kowal-Bielecka O, Kowal K, Distler O et al (2005) Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators. Arthritis Rheum 52:3783–3791. doi:10.1002/art.21432
185. Levy BD, Vachier I, Serhan CN (2012) Resolution of inflammation in asthma. Clin Chest Med 33:559–570. doi:10.1016/j.ccm.2012.06.006
186. Freedman SD, Blanco PG, Zaman MM et al (2004) Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350:560–569. doi:10.1056/NEJMoa021218
187. Haworth O, Cernadas M, Levy BD (2011) NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. J Immunol 186:6129–6135. doi:10.4049/jimmunol.1004007
188. Rogerio AP, Haworth O, Croze R et al (2012) Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol 189:1983–1991. doi:10.4049/jimmunol.1101665
189. Haworth O, Cernadas M, Yang R et al (2008) Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 9:873–879. doi:10.1038/ni.1627
190. Winkler J, Orr S, Dalli J et al (2015) Resolvin D4 potent antiiinflammatory proresolving actions confirmed via total synthesis. FASEB J 29:285.10
191. Winkler JW, Orr SK, Dalli J et al (2016) Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance. Sci Rep 6:18972. doi:10.1038/srep18972
192. Levy BD, Kohli P, Gotlinger K et al (2007) Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 178:496–502
193. Freire MO (2000) Van Dyke TE (2013) Natural resolution of inflammation. Periodontol 63:149–164. doi:10.1111/prd.12034
194. Basil MC, Levy BD (2016) Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 16:51–67. doi:10.1038/nri.2015.4
195. Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159–175. doi:10.1038/nri3399
196. José R, Williams A, Sulikowski M et al (2015) Regulation of neutrophilic inflammation in lung injury induced by community-acquired pneumonia. Lancet 385(Suppl 1):S52. doi:10.1016/S0140-6736(15)60367-1
197. Akinosoglou K, Alexopoulos D (2014) Use of antiplatelet agents in sepsis: a glimpse into the future. Thromb Res 133:131–138. doi:10.1016/j.thromres.2013.07.002
198. de Boer JD, Kager LM, Roelofs JJTH et al (2014) Overexpression of activated protein C hampers bacterial dissemination during pneumococcal pneumonia. BMC Infect Dis 14:559. doi:10.1186/s12879-014-0559-3
199. Arnold FW, Bordon J, Fernandez-Botran R et al (2015) Macrolide use and neutrophil function/cytokine levels in hospitalized patients with community-acquired pneumonia: a pilot study. Lung. doi:10.1007/s00408-015-9822-7
200. Mandal P, Chalmers JD, Graham C et al (2014) Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial. Lancet Respir Med 2:455–463. doi:10.1016/S2213-2600(14)70050-5
201. Troeman DPR, Postma DF, van Werkhoven CH, Oosterheert JJ (2013) The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review. J Infect 67:93–101. doi:10.1016/j.jinf.2013.04.015
202. Moret I, Lorenzo MJ, Sarria B et al (2011) Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia. Eur Respir J 38:1158–1164. doi:10.1183/09031936.00190410
203. Rossi AG, Sawatzky DA, Walker A et al (2006) Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 12:1056–1064. doi:10.1038/nm1468
204. Hoogendijk AJ, Roelofs JJTH, Duitman J et al (2012) R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae. Mol Med 18:1086–1095. doi:10.2119/molmed.2012.00033
205. Lucas CD, Dorward DA, Tait MA et al (2014) Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung. Mucosal Immunol 7:857–868. doi:10.1038/mi.2013.102
206. Castro CY (2006) ARDS and diffuse alveolar damage: a pathologist’s perspective. Semin Thorac Cardiovasc Surg 18:13–19. doi:10.1053/j.semtcvs.2006.02.001
207. Piantadosi CA, Schwartz DA (2004) The acute respiratory distress syndrome. Ann Intern Med 141:460–470
208. Estenssoro E, Dubin A, Laffaire E et al (2002) Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med 30:2450–2456. doi:10.1097/01.CCM.0000034692.46267.02
209. Steinberg KP, Milberg JA, Martin TR et al (1994) Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 150:113–122. doi:10.1164/ajrccm.150.1.8025736
210. Headley AS, Tolley E, Meduri GU (1997) Infections and the inflammatory response in acute respiratory distress syndrome. Chest 111:1306–1321
211. Steinberg KP, Hudson LD, Goodman RB et al (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684. doi:10.1056/NEJMoa051693
212. Meduri GU, Marik PE, Chrousos GP et al (2008) Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 34:61–69. doi:10.1007/s00134-007-0933-3
213. Peter JV, John P, Graham PL et al (2008) Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 336:1006–1009. doi:10.1136/bmj.39537.939039.BE
214. Tang BMP, Craig JC, Eslick GD et al (2009) Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 37:1594–1603. doi:10.1097/CCM.0b013e31819fb507
215. Kawashima M, Yatsunami J, Fukuno Y et al (2014) Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. Lung 180:73–89. doi:10.1007/PL00021246
216. Leiva M, Ruiz-Bravo A, Jimenez-Valera M (2008) Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation. Chest 134:20–29. doi:10.1378/chest.07-3056
217. Noto MJ, Wheeler AP (2012) Macrolides for acute lung injury. Chest 141:1131–1132. doi:10.1378/chest.11-3245
218. Walkey AJ, Wiener RS (2012) Macrolide antibiotics and survival in patients with acute lung injury. Chest 141:1153–1159. doi:10.1378/chest.11-1908
219. Bernard GR, Wheeler AP, Russell JA et al (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336:912–918. doi:10.1056/NEJM199703273361303
220. Heijerman H (2005) Infection and inflammation in cystic fibrosis: a short review. J Cyst Fibros 4(Suppl 2):3–5. doi:10.1016/j.jcf.2005.05.005
221. Mott LS, Park J, Murray CP et al (2012) Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 67:509–516. doi:10.1136/thoraxjnl-2011-200912
222. Lipuma JJ (2010) The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 23:299–323. doi:10.1128/CMR.00068-09
223. Cohen TS, Prince A (2012) Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 18:509–519. doi:10.1038/nm.2715
224. Adriaanse MPM, van der Sande LJTM, van den Neucker AM et al (2015) Evidence for a cystic fibrosis enteropathy. PLoS One 10:e0138062. doi:10.1371/journal.pone.0138062
225. Ramsey BW, Davies J, McElvaney NG et al (2011) A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 365:1663–1672. doi:10.1056/NEJMoa1105185
226. Painter RG, Valentine VG, Lanson NA et al (2006) CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 45:10260–10269. doi:10.1021/bi060490t
227. Moriceau S, Lenoir G, Witko-Sarsat V (2010) In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance. J Innate Immun 2:260–266. doi:10.1159/000295791
228. Vandivier RW, Fadok VA, Hoffmann PR et al (2002) Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 109:661–670. doi:10.1172/JCI13572
229. Sedor J, Hogue L, Akers K et al (2007) Cathepsin-G interferes with clearance of Pseudomonas aeruginosa from mouse lungs. Pediatr Res 61:26–31. doi:10.1203/01.pdr.0000250043.90468.c2
230. Konstan MW, Byard PJ, Hoppel CL, Davis PB (1995) Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 332:848–854. doi:10.1056/NEJM199503303321303
231. Ren CL, Pasta DJ, Rasouliyan L et al (2008) Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis. J Pediatr 153:746–751. doi:10.1016/j.jpeds.2008.07.010
232. Pizzutto SJ, Upham JW, Yerkovich ST, Chang AB (2010) Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis. Cochrane Database Syst Rev CD007525. doi: 10.1002/14651858.CD007525.pub2
233. Konstan MW, Walenga RW, Hilliard KA, Hilliard JB (1993) Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 148:896–901. doi:10.1164/ajrccm/148.4_Pt_1.896
234. Stelmach I, Korzeniewska A, Stelmach W et al (2005) Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis. Ann Allergy Asthma Immunol 95:372–380. doi:10.1016/S1081-1206(10)61156-8
235. Tateda K, Ishii Y, Matsumoto T et al (2000) Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response. J Infect Chemother 6:1–7. doi:10.1007/s101560000013
236. Schultz MJ (2004) Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemother 54:21–28. doi:10.1093/jac/dkh309
237. Southern KW, Barker PM, Solis-Moya A, Patel L (2012) Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev 11:CD002203. doi:10.1002/14651858.CD002203.pub4
238. Zarogoulidis P, Papanas N, Kioumis I et al (2012) Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol 68:479–503. doi:10.1007/s00228-011-1161-x
239. Binder AM, Adjemian J, Olivier KN, Prevots DR (2013) Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med 188:807–812. doi:10.1164/rccm.201307-1200OC
240. Jouneau S, Bonizec M, Belleguic C et al (2011) Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis. PLoS One 6:e22655. doi:10.1371/journal.pone.0022655
241. Ilmarinen P, Kankaanranta H (2014) Eosinophil apoptosis as a therapeutic target in allergic asthma. Basic Clin Pharmacol Toxicol 114:109–117. doi:10.1111/bcpt.12163
242. Joos S, Miksch A, Szecsenyi J et al (2008) Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 63:453–462. doi:10.1136/thx.2007.081596
243. Duffin R, Leitch AE, Sheldrake TA et al (2009) The CDK inhibitor, R-roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1. FEBS Lett 583:2540–2546. doi:10.1016/j.febslet.2009.07.017
244. Alessandri AL, Duffin R, Leitch AE et al (2011) Induction of eosinophil apoptosis by the cyclin-dependent kinase inhibitor AT7519 promotes the resolution of eosinophil-dominant allergic inflammation. PLoS One 6:e25683. doi:10.1371/journal.pone.0025683
245. Farahi N, Uller L, Juss JK et al (2011) Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance. Clin Exp Allergy 41:673–687. doi:10.1111/j.1365-2222.2010.03680.x
246. Reis AC, Alessandri AL, Athayde RM et al (2015) Induction of eosinophil apoptosis by hydrogen peroxide promotes the resolution of allergic inflammation. Cell Death Dis 6, e1632. doi:10.1038/cddis.2014.580
247. Starosta V, Pazdrak K, Boldogh I et al (2008) Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes. J Immunol 181:8688–8699
248. 4 promotes the resolution of allergic inflammation in the upper and lower airways of mice. Mucosal Immunol 8:852–862. doi:10.1038/mi.2014.116
249. Polier G, Ding J, Konkimalla BV et al (2011) Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis 2, e182. doi:10.1038/cddis.2011.66
250. Lucas CD, Allen KC, Dorward DA et al (2013) Flavones induce neutrophil apoptosis by down-regulation of Mcl-1 via a proteasomal-dependent pathway. Faseb J 27:1084–94. doi:10.1096/fj.12-218990, Epub 2012 Nov 29
251. Lucas CD, Dorward DA, Sharma S et al (2015) Wogonin induces eosinophil apoptosis and attenuates allergic airway inflammation. Am J Respir Crit Care Med 191:626–636. doi:10.1164/rccm.201408-1565OC